Cataract Surgery Devices Market Report Scope and Overview:

The Cataract Surgery Devices Market was valued at USD 9.00 Billion in 2025 and is projected to reach USD 14.25 Billion by 2035, registering a CAGR of 4.7% from 2026 to 2035.

The Cataract Surgery Devices Market is steadily advancing lens replacement surgery by combining premium intraocular lenses, phacoemulsification platforms, and femtosecond laser systems into increasingly precise, patient-personalized surgical workflows. The market is characterized by rising adoption of presbyopia-correcting and extended depth of focus intraocular lenses, growing integration of femtosecond laser-assisted capsulotomy and fragmentation into standard phacoemulsification workflows and expanding demand for viscoelastic devices that protect delicate ocular tissue during lens extraction. Significant growth is being witnessed in ambulatory surgery center deployments and next-generation multi-detection surgical consoles, considering that hospitals, ophthalmology clinics and device manufacturers continue investing in surgical infrastructure that improves visual outcomes and reduces complication rates.

Alcon launched its UNITY Vitreoretinal Cataract System and UNITY Cataract System in April 2025, featuring the HYPERVIT 30K vitrectomy probe and UNITY 4D Phaco technology delivering faster nucleus removal, reflecting the industry's broader shift toward unified, multi-procedure surgical platforms.

Cataract Surgery Devices Market Trends

• Rising adoption of presbyopia-correcting and extended depth of focus intraocular lenses continues expanding premium lens revenue.

• Growing integration of femtosecond laser-assisted capsulotomy continues improving precision across standard phacoemulsification workflows.

• Expanding deployment of multi-procedure surgical consoles continues consolidating vitreoretinal and cataract capability into single platforms.

• Increasing shift of cataract procedures toward ambulatory surgery centers continues extending device demand beyond hospitals.

• Rising strategic consolidation among device manufacturers continues reshaping the competitive cataract surgery device vendor landscape.

U.S. Cataract Surgery Devices Market Outlook

The U.S. Cataract Surgery Devices Market was valued at approximately USD 2.91 Billion in 2025 and is projected to reach approximately USD 4.20 Billion by 2035, registering a CAGR of approximately 4.2% from 2026 to 2035.

Demand across the United States continued to be shaped by high cataract procedure volumes among an aging population, growing patient willingness to pay for premium presbyopia-correcting lenses, and expanding surgeon preference for femtosecond laser-assisted precision over conventional manual techniques. Rising deployment of advanced phacoemulsification platforms by leading hospital systems and ambulatory surgery centers continued reinforcing the country's position as the largest and most technologically advanced cataract surgery devices market. Growing adoption of extended depth of focus and trifocal lenses added further layers of sustained domestic demand, with expanding patient education programs increasingly relying on spectacle-independence outcomes to support premium lens uptake.

Johnson & Johnson Vision continued expanding adoption of its TECNIS Odyssey full visual range intraocular lens throughout the year, reaching a milestone of 100,000 lenses implanted in September, 2025, across American ophthalmology practices and ambulatory surgery centers.

Cataract Surgery Devices Market Segment Analysis

• By Product Type, Intra-ocular Lenses segment dominated the Cataract Surgery Devices Market in 2025 with 48% share; Femtosecond Laser Systems segment is the fastest growing segment with a CAGR of approximately 7.8%.

• By Surgery Technique, Phaco-based Standard Surgery segment dominated the Cataract Surgery Devices Market in 2025 with 61% share; Femtosecond-Laser-Assisted Cataract Surgery segment is the fastest growing segment with a CAGR of approximately 8.2%.

• By End User, Hospitals segment dominated the Cataract Surgery Devices Market in 2025 with 44% share; Ambulatory Surgery Centers segment is the fastest growing segment with a CAGR of approximately 7.5%.

By Product Type: Intra-ocular Lenses Lead, Femtosecond Laser Systems Grow Fastest

The Intra-ocular Lenses segment dominated the Cataract Surgery Devices Market in 2025, driven by the universal requirement for a replacement lens in every cataract procedure and rising patient willingness to upgrade to premium presbyopia-correcting and toric options. Replacement and expansion of monofocal lens portfolios across hospitals sustained steady lens revenue as surgeons offered patients broader premium upgrade choices. Growing preference for extended depth of focus and trifocal lens platforms that reduce spectacle dependence reinforced this segment's position as the largest contributor to total market spending throughout the base year. Continued expansion of blue light filtering lens technology further reinforced premium lens adoption among discerning patients.

The Femtosecond Laser Systems segment is the fastest growing in the Cataract Surgery Devices Market owing to rising demand for laser-assisted capsulotomy, fragmentation, and astigmatism-correcting arcuate incisions that improve surgical precision. Growing adoption of multi-mode femtosecond platforms capable of supporting both cataract and corneal refractive procedures continues expanding recurring device demand beyond conventional phacoemulsification. Rising vendor investment in robotic femtosecond laser integration is accelerating this segment's growth trajectory across hospital and ambulatory surgery center settings worldwide. Growing surgeon confidence in laser-assisted astigmatism correction continues expanding adoption among toric cases.

By Surgery Technique: Phaco-Based Surgery Dominates, FLACS Grows Fastest

The Phaco-based Standard Surgery segment dominated the Cataract Surgery Devices Market in 2025 because ultrasound-based emulsification remains the most widely practiced, cost-effective technique for lens removal across the vast majority of installed surgical platforms worldwide. Broad surgeon familiarity, combined with continuous refinement of fluidics and energy delivery systems that reduce corneal trauma, sustained phaco-based surgery's dominant position throughout the base year. Continued refinement of adaptive fluidics technology compatible with standard consoles reinforced this technique's leading contribution to total market revenue. Continued expansion of predictive infusion management compatible with existing consoles further reinforced this technique's broad installed base.

The Femtosecond-Laser-Assisted Cataract Surgery segment is the fastest growing due to rising demand for laser precision in capsulotomy sizing, lens fragmentation, and astigmatism correction among complex and premium lens cases. Growing clinical evidence supporting FLACS's role in reducing endothelial cell loss continues expanding adoption among premium-lens and complex cataract surgeons. Rising vendor investment in more affordable, compact femtosecond platforms is accelerating this technique's transition from specialized use toward broader ambulatory surgery center adoption. Growing clinical training programs focused on laser capsulotomy continue expanding adoption confidence.

By End User: Hospitals Dominate, Ambulatory Surgery Centers Grow Fastest

The Hospitals segment dominated the Cataract Surgery Devices Market because hospitals remain the primary site of complex cataract cases, combined procedures, and surgical training programs requiring full device infrastructure support. Large hospital systems continue operating the highest procedure volumes globally, sustaining consistent capital equipment, lens, and viscoelastic consumable demand. Continued investment in dedicated ophthalmic surgical suites within hospital systems reinforced this segment's dominant contribution to total market revenue throughout the base year. Continued expansion of academic ophthalmology training programs within hospital systems further reinforced hospital-based device technology leadership.

The Ambulatory Surgery Centers segment is the fastest growing as outpatient cataract procedure volumes continue shifting from traditional hospital settings toward lower-cost, efficiency-focused ambulatory facilities requiring compact, high-throughput surgical platforms. Growing numbers of same-day cataract procedures increasingly rely on streamlined phacoemulsification and lens delivery systems suited to high-volume ambulatory workflows. Expanding investment in ambulatory surgery center infrastructure continues attracting a broadening base of facilities toward advanced cataract device adoption. Growing insurer support for outpatient cataract procedure reimbursement continues accelerating ambulatory surgery center device adoption nationwide.

Regional Analysis

North America Cataract Surgery Devices Market Insights

North America dominated the Cataract Surgery Devices Market with the largest revenue share of approximately 38.0% in 2025. Robust hospital and ambulatory surgery center infrastructure, significant ophthalmic device manufacturer presence, and high per-capita cataract procedure volumes continued reinforcing this dominant regional position. A deep concentration of leading device vendors, ophthalmology training centers, and integrated health systems headquartered across the region gave regional surgeons early access to next-generation premium lens and femtosecond laser platforms well ahead of most other regions. Growing collaboration between academic medical centers and device manufacturers further reinforced this region's technology leadership position.

The United States accounted for the substantial majority of regional revenue, anchored by high cataract procedure volumes among an aging population, growing patient willingness to pay for premium presbyopia-correcting lenses, and expanding surgeon preference for femtosecond laser-assisted precision. Canada added further demand through its own growing ophthalmology infrastructure investment, and that combined strength kept the region the largest addressable market for cataract surgery device vendors through the forecast period. Continued expansion of premium lens patient education programs across major metropolitan practices reinforced sustained device demand throughout the period.

Europe Cataract Surgery Devices Market Insights

Europe held a meaningful share of global revenue, supported by strong national health system investment, growing adoption of premium intraocular lenses, and continued collaborative research programs between hospitals and device manufacturers across the region's major economies. Regulatory harmonization under the EU Medical Device Regulation and continued expansion of national cataract surgery reimbursement programs continued lowering historically significant barriers to advanced cataract device technology adoption across the continent. Continued expansion of national premium lens reimbursement pilot programs further reinforced regional device technology adoption across public hospital networks.

Germany continued to lead demand at roughly 20.80% of European revenue, supported by its substantial hospital infrastructure and high cataract procedure volumes among the region's largest economies. The UK and France contributed substantial additional demand through their own well-funded national health systems and growing premium lens adoption programs, and continued European investment in ophthalmic surgical infrastructure should keep regional demand for cataract surgery devices climbing through the forecast period. Additional demand from Italy and Spain reinforced broader Southern European market strength throughout the forecast period.

Asia Pacific Cataract Surgery Devices Market Insights

Asia Pacific is advancing at the fastest pace, growing at a CAGR of approximately 6.8% from 2026 to 2035. This growth is driven by expanding hospital infrastructure and rising cataract procedure volumes in China, Japan, and India, rising government initiatives to strengthen domestic ophthalmic surgical capacity, with expanding hospital infrastructure continuing to broaden the region's addressable installation base well beyond its traditional smaller footprint. Rising medical tourism volumes across the region further reinforced demand for advanced cataract surgery device infrastructure.

China held a substantial share of regional revenue, supported by product launches from major market players and rapid expansion of domestic hospital ophthalmic surgery infrastructure. India and Japan contributed meaningful additional demand, with India's exceptionally high cataract procedure volumes and Japan's advanced device manufacturing base both reinforcing the region's position as the fastest-growing market tracked in this report, with all three countries expected to hold the major share of regional revenue. South Korea and Australia contributed smaller but steadily growing regional demand throughout the period.

MEA and Latin America Cataract Surgery Devices Market Insights

The Middle East and Africa and Latin America both showed steady growth, driven by expanding hospital infrastructure, rising government investment in healthcare modernization, and growing demand for locally accessible cataract surgery capability across both areas. As these markets continued building out modern hospital infrastructure, cataract surgery device technology proved a genuinely efficient way to expand advanced surgical capability without the decades-long buildout wealthier nations required. Growing medical tourism investment across both regions further reinforced demand for advanced ophthalmic surgical infrastructure.

Saudi Arabia led Middle East and Africa demand, supported by the country's substantial healthcare infrastructure investment under its national hospital expansion programs. The UAE contributed further demand through its own expanding private hospital network. In Latin America, Brazil accounted for the largest share of regional revenue, with growing hospital construction and ophthalmic surgery investment continuing to anchor regional demand for cataract surgery devices. Mexico contributed additional demand through expanding private hospital ophthalmic surgery investment.

Market Dynamics

Growth Drivers: Rising Cataract Prevalence and Growing Premium IOL Adoption

The industry is driven by rising global cataract prevalence among aging populations, growing patient demand for premium presbyopia-correcting and toric intraocular lenses, increasing surgeon preference for femtosecond laser-assisted precision, and expanding ambulatory surgery center adoption. As hospitals and ophthalmology clinics continue prioritizing visual outcomes and patient satisfaction, the need for advanced cataract surgery device technology continues driving adoption across both inpatient and outpatient surgical settings worldwide. Growing hospital investment in dedicated ophthalmic surgical suites further reinforces this sustained industry-wide demand driver.

Rising clinical evidence supporting premium intraocular lens platforms over conventional monofocal options continues reinforcing this driver, as more surgeons offer patients extended depth of focus and trifocal lenses that reduce spectacle dependence. Growing integration of femtosecond laser precision directly into standard phacoemulsification workflows continues improving surgical confidence, and that combination of premium lens innovation and laser integration is exactly what keeps demand climbing at such a steady, sustained pace. Expanding surgeon training partnerships between device manufacturers and academic institutions is further widening this addressable base.

Restraints: High Premium Lens Costs and Reimbursement Limitations

The substantial cost of premium presbyopia-correcting lenses and femtosecond laser systems continues posing a genuine restraint on faster market-wide expansion, particularly across smaller clinics and ambulatory centers in developing regions without the capital budgets that large hospital networks can commit. That cost profile has kept large-scale, premium lens adoption concentrated among a comparatively small number of well-resourced practices and patients able to pay out of pocket. Extended patient financing approval cycles discourage rapid premium lens adoption among cost-sensitive practices.

Inconsistent insurance reimbursement for premium presbyopia-correcting lenses and femtosecond laser procedures continues posing a further restraint, as many national health systems cover only standard monofocal lens and manual phacoemulsification costs. That reimbursement gap keeps some patients reliant on conventional monofocal lenses rather than upgrading to advanced premium technology of their own choosing. Limited standardization of premium lens coverage policies continues prolonging this regional adoption gap.

Opportunities: FLACS Expansion and Emerging Market Surgical Volume Growth

Rising investment in femtosecond laser-assisted cataract surgery and premium lens platforms represents a significant opportunity, as surgeons increasingly seek technology capable of improving precision without extending operative time. Vendors positioned early in robotic laser integration and next-generation lens materials stand to capture meaningful share as this capability continues expanding from premium-only cases into mainstream standard cataract surgery workflows. Expanding academic partnerships focused on next-generation lens material science continue widening this addressable opportunity.

Closing surgical infrastructure gaps across emerging ophthalmic markets offers a second substantial opportunity, as rising government healthcare spending and hospital construction initiatives continue creating fresh demand for accessible cataract surgery device infrastructure. Vendors with proven, cost-effective device platforms stand to capture meaningful share as developing economies increasingly expand hospital ophthalmic surgery capacity to support rising cataract procedure volumes at scale. Continued government-backed hospital accreditation programs across Southeast Asia are further accelerating local technology adoption.

Recent Developments:

• 2025: Bausch + Lomb continued expanding adoption of its Stellaris Elite phacoemulsification platform's Adaptive Fluidics technology, combining aspiration control with predictive infusion management for efficient lens removal.

• 2026 – ZEISS announced successful early clinical implantations of its new AT LUCIA toric 721P IOL, an astigmatism-correcting lens featuring an aspheric bitoric optic, patented ZO non-constant aberration design, and fully preloaded hydrophobic c-loop platform. Early-access implantation is being conducted across six European countries.

• 2026 –BVI’s Virtuoso dual-function phaco-vitrectomy platform received the CE Mark, clearing it for European commercialization. The system combines cataract phacoemulsification and vitreoretinal surgery capabilities in one platform, with European launch targeted for Q3 2026.

Cataract Surgery Devices Market key players are:

• Alcon Inc.

• Johnson & Johnson Vision

• Bausch + Lomb Corporation

• Carl Zeiss Meditec AG

• Hoya Corporation

• STAAR Surgical Company

• Rayner Group

• SIFI S.p.A.

• Ziemer Ophthalmic Systems AG

• Nidek Co., Ltd.

• Topcon Corporation

• LENSAR, Inc.

• Lumenis Be Ltd.

• Glaukos Corporation

• RxSight, Inc.

• Aurolab

• Appasamy Associates

• Lenstec, Inc.

• Medicontur Medical Engineering Ltd.

• Oertli Instrumente AG

Cataract Surgery Devices Market Report Scope: